Biofrontera Inc. BFRI

Healthcare — Drug Manufacturers Specialty & Generic

1.18 (0.02) (1.67%) as of 25 Sep

Market cap: $17.8M
P/E: 0.0×

Follow BFRI

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '17	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
P/E ratio Full definition →	—	0.00	0.00	0.00	28.17	0.00	0.00	0.00
P/S ratio Full definition →	—	1.94	1.94	2.75	0.62	0.13	0.16	0.14
P/FCF ratio Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	—	(28.99)	(28.99)	(3.16)	(2.16)	(0.49)	(5.91)	(2.44)
P/B ratio Full definition →	—	0.00	0.00	5.84	0.75	0.90	1.36	0.55
Price to Tangible BV Full definition →	—	0.00	0.00	8.40	0.86	2.00	1.37	0.74
EV/Sales Full definition →	—	1.85	1.85	1.73	(0.30)	0.22	0.12	0.10
EV/EBITDA Full definition →	—	0.00	0.00	0.00	0.49	0.00	0.00	0.00
EV/Operating CF Full definition →	—	(5.25)	(5.25)	(1.56)	0.53	(0.30)	(0.44)	(0.32)
EV/FCF Full definition →	—	(5.25)	(5.25)	(1.56)	0.53	(0.30)	(0.44)	(0.32)
Quick Ratio Full definition →	—	1.03	2.57	2.67	1.68	0.36	0.93	1.15
Current Ratio Full definition →	—	2.00	4.43	3.36	2.06	1.28	1.72	1.52
Net Debt/EBITDA Full definition →	—	(2.17)	0.89	1.00	1.52	(0.11)	0.11	0.17
Debt/Assets Full definition →	0.00%	132.86%	0.00%	0.00%	2.65%	13.98%	18.54%	16.07%
Debt/Equity Full definition →	—	(1.27)	0.00	0.00	0.06	0.81	0.92	0.44
Asset Turnover Full definition →	—	1.82	0.71	0.62	0.55	0.86	1.49	1.65
Operating CF/Net income Full definition →	—	3.43	1.13	0.71	25.31	1.24	0.58	1.27
Capex/Depreciation Full definition →	—	0.00	0.00	(0.02)	(0.03)	0.00	(0.05)	0.00
Interest Coverage Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE Full definition →	—	90.20%	90.24%	(439.39%)	(3.63%)	(140.43%)	(384.98%)	(141.30%)
ROA Full definition →	—	(76.39%)	(41.55%)	(97.50%)	(1.23%)	(51.08%)	(70.99%)	(41.59%)
ROIC Full definition →	—	0.00%	0.00%	0.00%	0.00%	(194.79%)	(410.70%)	(81.82%)
Return on Tangible Assets Full definition →	—	(89.80%)	(70.77%)	(114.80%)	(2.85%)	(393.11%)	(202.75%)	(126.24%)
Average Days of Receivables Full definition →	—	66.72	63.69	188.27	94.27	55.30	51.98	63.81
Research and Development Expense of Revenue Full definition →	—	0.00%	0.00%	0.00%	0.00%	0.23%	5.60%	8.92%
Selling, General and Administrative Expense of Revenue Full definition →	—	107.05%	96.12%	154.39%	125.10%	114.84%	90.66%	92.00%
Intangible Assets out of Total Assets Full definition →	0.00	0.15	0.16	0.06	0.06	0.09	0.00	0.09
Share Based Compensation of Revenue Full definition →	—	0.00%	0.00%	0.54%	6.46%	3.07%	2.73%	2.28%
Graham Net Nets Full definition →	—	(0.64)	(0.64)	0.07	0.90	(0.01)	0.50	0.00
Graham Number Full definition →	—	0.00	0.00	0.00	17.46	0.00	0.00	0.00
Earnings Yield Full definition →	—	(67,752.82%)	(67,752.82%)	(55.71%)	3.55%	(565.00%)	(295.12%)	(180.70%)
Free Cash Flow Yield Full definition →	—	(18.11%)	(18.11%)	(40.35%)	(90.90%)	(575.11%)	(170.97%)	(230.48%)
Revenue per Share Full definition →	—	43.13	17,135.45	54.72	27.13	22.03	6.77	4.10
Operating CF per Share Full definition →	—	(62.07)	(11,244.55)	(60.66)	(15.33)	(16.10)	(1.86)	(1.31)
Capex per Share Full definition →	—	0.00	0.00	(0.02)	(0.04)	0.00	(0.01)	0.00
Free Cash Flow per Share Full definition →	—	(62.07)	(11,244.55)	(60.69)	(15.36)	(16.10)	(1.87)	(1.31)
Cash per Share Full definition →	—	12.03	7,345.45	55.73	26.26	0.92	1.07	0.63
Shareholders Equity per Share Full definition →	—	(49.72)	5,298.18	25.74	22.59	3.10	0.80	1.03
Interest Debt per Share Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share Full definition →	—	(49.72)	5,298.18	25.74	22.59	3.10	0.80	1.03
Free Cash Flow Full definition →	—	(37.68)	(12.37)	(26.73)	(16.24)	(24.90)	(10.33)	(13.36)
Working Capital Full definition →	—	11.73	15.16	32.59	22.25	4.99	8.68	6.19
Capital Expenditures Full definition →	—	(0.54)	—	(0.01)	(0.04)	0.00	(0.06)	0.00
Net Current Asset Value Full definition →	—	(35.46)	1.27	4.54	16.13	(0.06)	3.03	0.00
EV/EBIT Full definition →	—	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Capex to Sales Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin Full definition →	—	(41.95%)	(58.29%)	(156.49%)	(2.23%)	(59.09%)	(47.58%)	(25.26%)
Price to Operating Income Full definition →	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other line items
Depreciation/Fixed assets Full definition →	—	1.33	1.52	2.02	5.75	7.94	14.36	0.40
Cash ROIC Full definition →	—	(249.17%)	(91.59%)	(75.19%)	(30.96%)	(247.37%)	(71.66%)	(72.28%)
Accounts Receivable Turnover Full definition →	—	6.48	4.67	3.07	2.89	5.42	7.12	6.62
Accounts Payable Turnover Full definition →	—	2.74	1.90	9.60	8.60	3.01	2.30	1.58
Inventory Turnover Full definition →	—	1.49	1.03	2.21	2.61	1.93	2.12	2.72
Average Days of Payables Full definition →	—	218.13	69.01	26.93	62.26	188.44	141.24	221.92
Days of Inventory on Hand Full definition →	—	292.56	285.49	127.70	172.30	228.24	130.37	47.47
Average Receivables Full definition →	—	4.04	4.04	7.86	9.92	6.28	5.24	6.30
Average Payables Full definition →	—	4.76	4.76	1.33	1.77	5.80	8.10	6.93
Average Inventory Full definition →	—	8.79	8.79	5.77	5.81	9.04	8.78	4.04
Average Assets Full definition →	—	14.38	26.45	38.68	52.05	39.41	25.02	25.33
Average Common Equity Full definition →	—	(12.18)	(12.18)	8.58	17.61	14.34	4.61	7.46

Fold the line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Biofrontera Inc. BFRI

Biofrontera Inc. BFRI

Stockrow Weekly